Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases.

Meserve, Joseph; Aniwan, Satimai; Koliani-Pace, Jenna L; Shashi, Preeti; Weiss, Aaron; Faleck, David; Winters, Adam; Chablaney, Shreva; Kochhar, Gursimran; Boland, Brigid S; Singh, Siddharth; Hirten, Robert; Shmidt, Eugenia; Hartke, Justin G; Chilukuri, Prianka; Bohm, Matthew; Sagi, Sashidhar Varma; Fischer, Monika; Lukin, Dana; Hudesman, David; Chang, Shannon; Gao, Youran; Sultan, Keith; Swaminath, Arun; Gupta, Nitin; Kane, Sunanda; Loftus, Edward V; Shen, Bo; Sands, Bruce E; Colombel, Jean-Frederic; Siegel, Corey A; Sandborn, William J; Dulai, Parambir S.
Clin Gastroenterol Hepatol; 2018 Sep 27.
Artigo em Inglês | MEDLINE | ID: mdl-30268561

Não foram localizados documentos relacionados